PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Chen, J.* ; Fleming, T.* ; Katz, S.* ; Dewenter, M.* ; Hofmann, K.* ; Saadatmand, A.* ; Kronlage, M.* ; Werner, M.P.* ; Pokrandt, B.* ; Schreiter, F.* ; Lin, J.* ; Katz, D.* ; Morgenstern, J.* ; Elwakiel, A.* ; Sinn, P.* ; Gröne, H.J.* ; Hammes, H.P.* ; Nawroth, P.P. ; Isermann, B.* ; Sticht, C.* ; Brügger, B.* ; Katus, H.A.* ; Hagenmueller, M.* ; Backs, J.*

CaM kinase II-δ is required for diabetic hyperglycemia and retinopathy but not nephropathy.

Diabetes 70, 616-626 (2021)
Postprint DOI PMC
Open Access Green
Type 2 diabetes has become a pandemic and leads to late diabetic complications of organs including kidney and eye. Lowering hyperglycemia is the typical therapeutic goal in clinical medicine. However, hyperglycemia may only be a symptom of diabetes but not the sole cause of late diabetic complications, Instead, other diabetes-related alterations could be causative. Here, we studied the role of CaM Kinase II δ (CaMKIIδ) that is known to be activated through diabetic metabolism. CaMKIIδ is expressed ubiquitously and might therefore affect several different organ systems. We crossed diabetic leptin receptor mutant mice to mice lacking CaMKIIδ globally. Remarkably, CaMKIIδ-deficient diabetic mice did not develop hyperglycemia. As potential underlying mechanisms, we provide evidence for improved insulin sensing with increased glucose transport into skeletal muscle but also reduced hepatic glucose production. Despite normoglycemia, CaMKIIδ-deficient diabetic mice developed the full picture of diabetic nephropathy but diabetic retinopathy was prevented. We also unmasked a retina-specific gene expression signature that might contribute to CaMKII-dependent retinal diabetic complications. These data challenge the clinical concept of normalizing hyperglycemia in diabetes as a causative treatment strategy for late diabetic complications and call for a more detailed analysis of intracellular metabolic signals in different diabetic organs.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
9.461
1.796
1
5
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Dependent Protein-kinase; Microvascular Complications; Glucose; Activation; Expression; Progression; Inhibitor; Duration; Pathway; Obesity
Sprache englisch
Veröffentlichungsjahr 2021
Prepublished im Jahr 2020
HGF-Berichtsjahr 2020
ISSN (print) / ISBN 0012-1797
e-ISSN 1939-327X
Zeitschrift Diabetes
Quellenangaben Band: 70, Heft: 2, Seiten: 616-626 Artikelnummer: , Supplement: ,
Verlag American Diabetes Association
Verlagsort Alexandria, VA.
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Diabetes and Cancer (IDC)
POF Topic(s) 90000 - German Center for Diabetes Research
Forschungsfeld(er) Helmholtz Diabetes Center
PSP-Element(e) G-501900-251
Förderungen German Research Foundation
Bundesministerium fur Bildung und Forschung (German Ministry of Education and Research)
Deutsches Zentrum fur Herz-Kreislauf-Forschung-German Centre for Cardiovascular Research
German Society for Cardiology
Deutsche Forschungsgemeinschaft
DOI 10.2337/db19-0659
WOS ID WOS:000609243500028
Scopus ID 85100280000
PubMed ID 33239449
Erfassungsdatum 2020-12-15
[➜Korrektur melden]